leagues report in this issue of the journal that the frequency of MC,a low complement level, and a high level of Clq were not significantly different between chronic HCVinfection patients with neuropathy and without neuropathy. This suggested that not only MCand its related proteins but other immunomodulatoryfactors may relate to the development of neuropathy in HCV-infected patients (1) .
See also p 394.
Although peripheral neuropathy may be associated with all types of cryoglobulinemias, it is a frequent complication in patients suffering from type II MC. MCis strongly associated with HCVinfection and characterized by high concentrations of anti-HCV antibodies and HCV RNA in the cryoprecipitates (2) . HCVinfection of peripheral mononuclear cells may be responsible for the clonal B-cell expansion underlying the systemic manifestations of MC(3). However, the role of cryoglobulins and/or HCVinfection in the development of peripheral neuropathy has yet to be elucidated (4).
The most widely accepted hypothesis is as follows: the formation of immunecomplexes is followed by their deposition in the vessel wall and by inflammation leading to the de- Tropism of HCVtowards blood mononuclearcells and hepatocytes and the persistence of this virus in these cells is well known, but neurotropism of HCVhas never been described. However, it may be possible that HCVvirus directly invades the peripheral nervous system. Bonetti et al (9) Future studies concerning the presence of HCVRNAin the central and peripheral nervous system are awaited. 
